October 7th 2016 –  Percepta Associates Inc. has been selected for the 2016 California Excellence Award for client services in market research among all its peers and competitors by the American Economic Institute (AEI).

Percepta Associates Inc. has consistently demonstrated a high regard for upholding business ethics and company values. This recognition by AEI marks a significant achievement as an emerging…

Smart mobile devices have changed our lives and we now walk around with the internet in our back pockets.   They help us shop, share information, and update our favorite social media profiles.   However, how people use mobile devices tends to vary depending on the task at hand (pun intended).  Many find their mobile devices to be useful in the…

In October 2013, we polled users of protein analysis products in the U.S. to understand how, if at all, budget sequestration has affected their lab’s purchase of protein analysis products.  Results reveal that both non-profit and for-profit researchers are impacted by budget sequestration as approximately 56% of non-profit and 29% of for-profit respondents indicated budget sequestration has definitely affected…

We set out to understand, at a top level, which life science suppliers are recognized in the industry for having the most flexible pricing options, for reagents and for instruments.  The questions posed to North American, European and Chinese audiences were:

Q. Which life science reagent supplier has the most flexible pricing options?

Q. Which life science instrument supplier…

With an Expected Decline to Low Single Digit Growth across Various Reporter Gene Assay Segments, Luciferase Assay Demand Remains Strong
Carlsbad, Calif. – August 30, 2013: Percepta Associates announces the launch of its Reporter Gene Assays Life Science Dashboard™ market research report revealing Life Technologies (including Invitrogen brand), Promega, Sigma Aldrich, Clontech, Thermo Fisher (including Pierce brand), Roche Applied Sciences…

Where do scientists charged with analyzing forensic DNA samples from crime scenes go when they want to stay current on new methods, trends and products?  We recently learned it may not be the same place as other scientists undertaking similar tasks like DNA-based paternity testing, human cell line identification and human phenotype testing.

In a recent survey, we asked over…

Life Technologies Dominates the Market, while Abcam and BD Biosciences Maintain a Strong Presence.
Carlsbad, Calif. – March 11, 2013: Percepta Associates announces the launch of its Fluorescent Imaging Life Science Dashboard™ market research report revealing Life Technologies (including Molecular Probes and Invitrogen brands), Abcam and BD Biosciences as leading suppliers across various segments.  Market segments analyzed in this report…

However, GE/Amersham and Thermo Fisher Scientific Prevail for Certain Chemiluminescent ELISA Segments.

CARLSBAD, Calif.–(BUSINESS WIRE)–Today Percepta Associates launched its Quantitative Immunoassay Life Science Dashboard™ market research report revealing BD Biosciences, EMD Millipore, Life Technologies, Meso Scale Discovery and R&D Systems as leading suppliers in the immunoassay market which includes: colorimetric, chemiluminescent and fluorescent ELISAs, as well as electrochemiluminescence and bead-based…

In February 2013 we polled our panel of fluorescent imaging reagent users regarding their anticipated laboratory budget. Data reveals that commercial users anticipate a slight increase compared to academic users. As shown in the table, 24.1% of commercial users of fluorescent imaging reagents expect their budget to increase over the next 12 months, vs. 17.6% of academic users (a…

If you thought cell therapy had suffered too many setbacks in recent years and was stuck in neutral – think again. In a recent Percepta poll of 250 randomly selected life science researchers working in biotechnology and pharmaceutical companies more than 20% are involved in projects focused on allogeneic or autologous cell therapy and/or regenerative medicine. Even more surprising…